Alves, S.K.S.; Sousa, C.S.; Viana, E.K.A.; Souza, H.C.A.; Souza, M.D.A.; Ribeiro, A.S.N.; Vale, V.d.S.d.; Islam, M.T.; Araújo, J.L.; Rocha, J.A.
Bioactive Components of Myracrodruon urundeuva against SARS-CoV-2: A Computational Study. Drugs Drug Candidates 2023, 2, 781-795.
https://doi.org/10.3390/ddc2040039
AMA Style
Alves SKS, Sousa CS, Viana EKA, Souza HCA, Souza MDA, Ribeiro ASN, Vale VdSd, Islam MT, Araújo JL, Rocha JA.
Bioactive Components of Myracrodruon urundeuva against SARS-CoV-2: A Computational Study. Drugs and Drug Candidates. 2023; 2(4):781-795.
https://doi.org/10.3390/ddc2040039
Chicago/Turabian Style
Alves, Sabrina Kelly Silva, Cássio Silva Sousa, Edilanne Katrine Amparo Viana, Hellen Cris Araújo Souza, Maycon Douglas Araújo Souza, Arthur Serejo Neves Ribeiro, Vanessa de Sousa do Vale, Muhammad Torequl Islam, Joabe Lima Araújo, and Jefferson Almeida Rocha.
2023. "Bioactive Components of Myracrodruon urundeuva against SARS-CoV-2: A Computational Study" Drugs and Drug Candidates 2, no. 4: 781-795.
https://doi.org/10.3390/ddc2040039
APA Style
Alves, S. K. S., Sousa, C. S., Viana, E. K. A., Souza, H. C. A., Souza, M. D. A., Ribeiro, A. S. N., Vale, V. d. S. d., Islam, M. T., Araújo, J. L., & Rocha, J. A.
(2023). Bioactive Components of Myracrodruon urundeuva against SARS-CoV-2: A Computational Study. Drugs and Drug Candidates, 2(4), 781-795.
https://doi.org/10.3390/ddc2040039
